Home / FAM219A Knockout Cell Lines

FAM219A Knockout Cell Lines

Gene: FAM219A

Official Full Name: family with sequence similarity 219 member Aprovided by HGNC

Gene Summary: The protein encoded by this gene has homologs that have been identified in mouse, macaque, etc organisms. Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene. [provided by RefSeq, Dec 2010]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO36032 FAM219A Knockout cell line (HeLa) Human FAM219A 1:3~1:6 Negative Online Inquiry
KO36033 FAM219A Knockout cell line (HCT 116) Human FAM219A 1:2~1:4 Negative Online Inquiry
KO36034 FAM219A Knockout cell line (HEK293) Human FAM219A 1:3~1:6 Negative Online Inquiry
KO36035 FAM219A Knockout cell line (A549) Human FAM219A 1:3~1:4 Negative Online Inquiry

Background

FAM219A Gene Knockout Cell Lines are a specialized biological research tool designed to facilitate the functional characterization of the FAM219A gene. These cell lines have been genetically engineered to contain deletions of the FAM219A gene, enabling researchers to elucidate its role in various cellular processes. By removing this gene, the cell lines serve as an invaluable model for studying the effects of gene loss on cell behavior, signaling pathways, and phenotypic outcomes.

The primary function of the FAM219A Gene Knockout Cell Lines lies in their ability to mimic specific genetic conditions, allowing for assessments of the gene's involvement in various biological systems. Researchers can utilize these cell lines to investigate cellular responses to stimuli, drug treatments, or stressors, thus unveiling critical insights into the underlying mechanisms that govern physiological and pathological states.

The scientific importance of FAM219A Gene Knockout Cell Lines extends across various domains, including cancer research, stem cell biology, and neurobiology. This product has the potential to serve as a platform for identifying novel therapeutic targets, understanding gene function in development and disease, and validating hypotheses in genetic studies. By enabling this level of investigation, the cell lines can aid in the discovery of biomarkers and therapeutic strategies relevant to conditions impacted by the FAM219A gene.

Compared to alternative gene editing methods, such as CRISPR/Cas9, FAM219A Gene Knockout Cell Lines offer distinct advantages in terms of consistency and reproducibility. These cell lines allow for high-throughput screening, lowering variability and enhancing the credibility of experimental results. Furthermore, they are ready to use and do not require extensive optimization, saving researchers significant time and resources.

For researchers and clinicians seeking to advance their work in gene function studies and therapeutic development, FAM219A Gene Knockout Cell Lines present a unique and powerful solution. With a focus on enhancing scientific discovery, our company is committed to providing high-quality, reliable biological products that empower the research community. With years of expertise in genetic engineering and cellular technologies, we stand ready to support the advancement of groundbreaking research and clinical applications.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.